Entasis Therapeutics Holdings Inc
ETTX
Get informed when a big investor buys or sells
+ FollowMarket Cap$0
Close$
$2.87
31.2% upside
Current Fair Value
31.2% upsideUndervalued by 31.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $-14,693,000.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1 |
| Beta | 1.33 |
| Outstanding Shares | 47,851,779 |
Return
| Return on Equity | -521.62% |
|---|---|
| Return on Assets | -196.95% |
| Return on Invested Capital | -435.25% |
Valuation & Multiples
| P/E Ratio | -2.2 |
|---|---|
| PEG | -5.15 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.17 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -1.28 |
| Debt to Equity | 1.13 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data